ArticlePLoS computational biology2025
A novel generative framework for designing pathogen-targeted antimicrobial peptides with programmable physicochemical properties.
Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Next-Generation Antimicrobial Peptides for Biofilm-Associated Infections: Engineering, Biomaterial Delivery and AI-Assisted Discovery.Antibiotics (Basel, Switzerland) · 2026Review
- Next-Generation Target Discovery in ESKAPE Pathogens: An AI-Driven Framework from Omics-Based to Systems-Level Modeling and Clinical Translation.Antibiotics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Antimicrobial peptides (AMPs) are crucial in addressing the global crisis of bacterial resistance. However, there are still significant limitations in existing methods on de novo AMPs design, especially in designing AMPs with desirable physicochemical properties for specific bacterial pathogens. In this study, we propose a novel generative framework for designing pathogen-targeted antimicrobial peptides with programmable physicochemical properties. More specifically, a conditional Variational Autoencoder is first pretrained for generating AMPs with editable physicochemical properties. We then develop a conditional diffusion model to learn hidden representations of AMPs for targeting pathogens of interest, and construct corresponding MIC predictors for specific bacterial strains. Through comprehensive simulation experiments, we demonstrate that the proposed framework outperforms most existing models in terms of antimicrobial efficacy against specific bacterial targets. Moreover, through systematic screening and analysis, we have identified two star AMPs for each of the two target bacterial species (i.e., E. coli or S. aureus), both of which exhibit excellent performance in antibacterial activity, hemolytic properties, toxicity profiles, etc. Overall, this study provides the key technological support for developing next-generation intelligent platforms for antimicrobial agents design.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.